Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 8, 2007

View Archived Issues

Valeant's Xyrem launched in Canada for narcoleptics with cataplexy

Lilly receives approval in Japan for Cialis for erectile dysfunction

Paget's disease indication submitted for risedronate sodium hydrate as orphan drug

Cognitive data reported from EPOLYM trial of epoetin alfa

Genentech completes acquisition of Tanox

Gruenenthal claims new analgesic drugs in recent patent literature

Recent patents claim new compounds for the treatment of infectious diseases

New treatment options for psychological disorders described in recent patents

CeNeS grants rights to Ono for new intravenous anesthetic in Japan

Deforolimus new nonproprietary name for Ariad's AP-23573

TURNS network evaluating two different treatments for cognitive impairment in schizophrenia

Kosan enrolls patients in phase II/III trial of Hsp90 inhibitor tanespimycin

Depot formulation of olanzapine provides therapeutic D2 receptor occupancy

Promising results from phase II study of Iomai's patch-based ETEC E. coli vaccine

Phase III studies show Vidaza significantly increases survival in MDS

Novel inhibitors of HIV-1 protease dimerization described

ImmunoGen begins phase II trial of huC242-DM4 for gastric cancer

Regeneron and Bayer begin phase III study of VEGF Trap-Eye for wet AMD

PF-04548043 enters phase I for GERD

Array to initiate phase I trial of ErbB-2 inhibitor ARRY-380 for cancer

Phase II trial of Antisoma's AS-1411 in AML begins

Hana Biosciences begins phase II trial of Marqibo for ALL

Innovive reaches SPA agreement with FDA for pivotal phase II trial of tamibarotene

First approval for Pfizer's novel HIV treatment

NVA-237 progressing through clinical trials for COPD

North American clinical evaluation of GSK prepandemic H5N1 vaccine commences

FDA will review sBLA for Orencia in juvenile arthritis

Lux Biosciences' LX-211 granted fast track designation for the treatment of uveitis

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...